Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 11-20 of 149 for Amyloidosis

Edit search filters
  1. A Study To Evaluate The Effectiveness And Safety Of CAEL-101 In Patients With Mayo Stage IIIa AL Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Evaluate The Effectiveness And Safety Of Vutrisiran In Patients With Transthyretin Amyloidosis With Cardiomyopathy (ATTR Amyloidosis With Cardiomyopathy

    Rochester, MN

  3. Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant To Dara-VCD Chemotherapy Alone For People Who Have Newly Diagnosed AL Amyloidosis

    Rochester, MN

  4. A Study To Evaluate The Efficacy And Safety Of Belantamab Mafodotin In Combination With Cyclophosphamide, Bortezomib, And Dexamethasone In Adult Participants With Newly Diagnosed Amyloid Light Chain Amyloidosis

    Rochester, MN

  5. A Phase 1b/2 Study Of CAR T Cell Therapy Targeting CD19 And BCMA In Participants With Relapsed Or Refractory AL Amyloidosis.

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. A Study To Evaluate The Safety And Effectiveness Of CAEL-101 And Plasma Cell Dyscrasia Treatment Vs. Placebo And Plasma Cell Dyscrasia Tretment To Treat Patients With Mayo Stage IIIb AL Amyloidosis

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  7. A Study Using Magnetic Resonance Elastography to Assess Heart Muscle Stiffness in Patients with Cardiac Amyloidosis

    Rochester, MN

  8. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis

    Scottsdale/Phoenix, AZ

  9. CLEOPATTRA: A Research Study To Look At The Effects Of Treatment With A Medicine Called Coramitug (NNC6019-0001) In People With Heart Failure Due To Transthyretin Amyloid (ATTR) Amyloidosis

    Rochester, MN

  10. A Study to Monitor Cardiac Amyloidosis Patients with Implantable Event Monitors

    Rochester, MN

.

Mayo Clinic Footer